Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 10, Number 9—September 2004

Volume 10, Number 9—September 2004   PDF Version [PDF - 5.68 MB - 195 pages]

Perspective

  • New Measurable Indicator for Tuberculosis Case Detection PDF Version [PDF - 285 KB - 6 pages]
    M. W. Borgdorff
        View Abstract

    The World Health Organization’s goal for tuberculosis (TB) control is to detect 70% of cases with a new, smear-positive TB test and cure 85% of these cases. The case detection rate is the number of reported cases per 100,000 persons per year divided by the estimated incidence rate per 100,000 per year. TB incidence is uncertain and not measured but estimated; therefore, the case detection rate is uncertain. This article proposes a new indicator to assess case detection: the patient diagnostic rate. The patient diagnostic rate is the rate at which prevalent cases are detected by control programs and can be measured as the number of reported cases per 100,000 persons per year divided by the prevalence per 100,000. Prevalence can be measured directly through national prevalence surveys. Conducting prevalence surveys at 5- to 10-year intervals would allow countries with high rates of disease to determine their case detection performance by using the patient diagnostic rate and determine the effect of control measures.

        Cite This Article
    EID Borgdorff MW. New Measurable Indicator for Tuberculosis Case Detection. Emerg Infect Dis. 2004;10(9):1523-1528. https://dx.doi.org/10.3201/eid1009.040349
    AMA Borgdorff MW. New Measurable Indicator for Tuberculosis Case Detection. Emerging Infectious Diseases. 2004;10(9):1523-1528. doi:10.3201/eid1009.040349.
    APA Borgdorff, M. W. (2004). New Measurable Indicator for Tuberculosis Case Detection. Emerging Infectious Diseases, 10(9), 1523-1528. https://dx.doi.org/10.3201/eid1009.040349.
        Email Email this Article
  • Potential Public Health Impact of New Tuberculosis Vaccines PDF Version [PDF - 358 KB - 7 pages]
    E. Ziv et al.
        View Abstract

    Developing effective tuberculosis (TB) vaccines is a high priority. We use mathematical models to predict the potential public health impact of new TB vaccines in high-incidence countries. We show that preexposure vaccines would be almost twice as effective as postexposure vaccines in reducing the number of new infections. Postexposure vaccines would initially have a substantially greater impact, compared to preexposure vaccines, on reducing the number of new cases of disease. However, the effectiveness of postexposure vaccines would diminish over time, whereas the effectiveness of preexposure vaccines would increase. Thus, after 20 to 30 years, post- or preexposure vaccination campaigns would be almost equally effective in terms of cumulative TB cases prevented. Even widely deployed and highly effective (50%–90% efficacy) pre- or postexposure vaccines would only be able to reduce the number of TB cases by one third. We discuss the health policy implications of our analyses.

        Cite This Article
    EID Ziv E, Daley CL, Blower S. Potential Public Health Impact of New Tuberculosis Vaccines. Emerg Infect Dis. 2004;10(9):1529-1535. https://dx.doi.org/10.3201/eid1009.030921
    AMA Ziv E, Daley CL, Blower S. Potential Public Health Impact of New Tuberculosis Vaccines. Emerging Infectious Diseases. 2004;10(9):1529-1535. doi:10.3201/eid1009.030921.
    APA Ziv, E., Daley, C. L., & Blower, S. (2004). Potential Public Health Impact of New Tuberculosis Vaccines. Emerging Infectious Diseases, 10(9), 1529-1535. https://dx.doi.org/10.3201/eid1009.030921.
        Email Email this Article
  • Deaths due to Unknown Foodborne Agents PDF Version [PDF - 119 KB - 8 pages]
    P. D. Frenzen
        View Abstract

    This study reviews the available evidence on unknown pathogenic agents transmitted in food and examines the methods that have been used to estimate that such agents cause 3,400 annual U.S. deaths per year in the United States. The estimate of deaths was derived from hospital discharge and death certificate data on deaths attributed to gastroenteritis of unknown cause. Fatal illnesses due to unknown foodborne agents do not always involve gastroenteritis, and gastroenteritis may not be accurately diagnosed or reported on hospital charts or death certificates. The death estimate consequently omitted deaths from unknown foodborne agents that do not cause gastroenteritis and likely overstated the number of deaths from agents that cause gastroenteritis. Although the number of deaths from unknown foodborne agents is uncertain, the possible economic cost of these deaths is so large that increased efforts to identify the causal agents are warranted.

        Cite This Article
    EID Frenzen PD. Deaths due to Unknown Foodborne Agents. Emerg Infect Dis. 2004;10(9):1536-1543. https://dx.doi.org/10.3201/eid1009.030403
    AMA Frenzen PD. Deaths due to Unknown Foodborne Agents. Emerging Infectious Diseases. 2004;10(9):1536-1543. doi:10.3201/eid1009.030403.
    APA Frenzen, P. D. (2004). Deaths due to Unknown Foodborne Agents. Emerging Infectious Diseases, 10(9), 1536-1543. https://dx.doi.org/10.3201/eid1009.030403.
        Email Email this Article

Synopses

  • Laboratory Exposures to Staphylococcal Enterotoxin B PDF Version [PDF - 175 KB - 6 pages]
    J. M. Rusnak et al.
        View Abstract

    Staphylococcal enterotoxins are 23- to 29-kDa polypeptides in the bacterial superantigen protein family. Clinical symptoms from intoxication with staphylococcal enterotoxins vary by exposure route. Ingestion results in gastrointestinal symptoms, and inhalation results in fever as well as pulmonary and gastrointestinal symptoms. Review of occupational exposures at the U.S. Army Medical Research Institute of Infectious Diseases from 1989 to 2002 showed that three laboratory workers had symptoms after ocular exposure to staphylococcal enterotoxin B (SEB). Conjunctivitis with localized cutaneous swelling occurred in three persons within 1 to 6 hours after exposure to SEB; two of these persons also had gastrointestinal symptoms, which suggests that such symptoms occurred as a result of exposure by an indirect cutaneous or ocular route. Ocular exposures from SEB resulting in conjunctivitis and localized swelling have not previously been reported. Symptoms from these patients and review of clinical symptoms of 16 laboratory-acquired inhalational SEB intoxications may help healthcare workers evaluate and identify SEB exposures in laboratory personnel at risk.

        Cite This Article
    EID Rusnak JM, Kortepeter MG, Ulrich R, Poli M, Boudreau E. Laboratory Exposures to Staphylococcal Enterotoxin B. Emerg Infect Dis. 2004;10(9):1544-1549. https://dx.doi.org/10.3201/eid1009.040250
    AMA Rusnak JM, Kortepeter MG, Ulrich R, et al. Laboratory Exposures to Staphylococcal Enterotoxin B. Emerging Infectious Diseases. 2004;10(9):1544-1549. doi:10.3201/eid1009.040250.
    APA Rusnak, J. M., Kortepeter, M. G., Ulrich, R., Poli, M., & Boudreau, E. (2004). Laboratory Exposures to Staphylococcal Enterotoxin B. Emerging Infectious Diseases, 10(9), 1544-1549. https://dx.doi.org/10.3201/eid1009.040250.
        Email Email this Article

Research

  • Viral Loads in Clinical Specimens and SARS Manifestations PDF Version [PDF - 195 KB - 8 pages]
    I. Hung et al.
        View Abstract

    A retrospective viral load study was performed on clinical specimens from154 patients with laboratory-confirmed severe acute respiratory syndrome (SARS), prospectively collected during patients’ illness. Viral load in nasopharyngeal aspirates (n = 142) from day 10 to day 15 after onset of symptoms was associated with oxygen desaturation, mechanical ventilation, diarrhea, hepatic dysfunction, and death. Serum viral load (n = 53) was associated with oxygen desaturation, mechanical ventilation, and death. Stool viral load (n = 94) was associated with diarrhea, and urine viral load (n = 111) was associated with abnormal urinalysis results. Viral replications at different sites are important in the pathogenesis of clinical and laboratory abnormalities of SARS.

        Cite This Article
    EID Hung I, Cheng V, Wu A, Tang B, Chan K, Chu C, et al. Viral Loads in Clinical Specimens and SARS Manifestations. Emerg Infect Dis. 2004;10(9):1550-1557. https://dx.doi.org/10.3201/eid1009.040058
    AMA Hung I, Cheng V, Wu A, et al. Viral Loads in Clinical Specimens and SARS Manifestations. Emerging Infectious Diseases. 2004;10(9):1550-1557. doi:10.3201/eid1009.040058.
    APA Hung, I., Cheng, V., Wu, A., Tang, B., Chan, K., Chu, C....Yuen, K. (2004). Viral Loads in Clinical Specimens and SARS Manifestations. Emerging Infectious Diseases, 10(9), 1550-1557. https://dx.doi.org/10.3201/eid1009.040058.
        Email Email this Article
  • SARS Antibody Test for Serosurveillance PDF Version [PDF - 100 KB - 5 pages]
    P. Hsueh et al.
        View Abstract

    A peptide-based enzyme-linked immunosorbent assay (ELISA) can be used for retrospective serosurveillance of severe acute respiratory syndrome (SARS) by helping identify undetected chains of disease transmission. The assay was developed by epitope mapping, using synthetic peptides from the spike, membrane, and nucleocapsid protein sequences of SARS-associated coronavirus. The new peptide ELISA consistently detected seroconversion by week 2 of onset of fever, and seropositivity remained through day 100. Specificity was 100% on normal blood donor samples, on serum samples associated with infection by other pathogens, and on an interference panel. The peptide-based test has advantages of safety, standardization, and automation over previous immunoassays for SARS. The assay was used for a retrospective survey of healthy healthcare workers in Taiwan who treated SARS patients. Asymptomatic seroconversions were detected in two hospitals that had nosocomial disease.

        Cite This Article
    EID Hsueh P, Kao C, Lee C, Chen L, Ho M, Sia C, et al. SARS Antibody Test for Serosurveillance. Emerg Infect Dis. 2004;10(9):1558-1562. https://dx.doi.org/10.3201/eid1009.040101
    AMA Hsueh P, Kao C, Lee C, et al. SARS Antibody Test for Serosurveillance. Emerging Infectious Diseases. 2004;10(9):1558-1562. doi:10.3201/eid1009.040101.
    APA Hsueh, P., Kao, C., Lee, C., Chen, L., Ho, M., Sia, C....Wang, C. Y. (2004). SARS Antibody Test for Serosurveillance. Emerging Infectious Diseases, 10(9), 1558-1562. https://dx.doi.org/10.3201/eid1009.040101.
        Email Email this Article
  • Experimental Infection of Ground Squirrels (Spermophilus tridecemlineatus) with Monkeypox Virus PDF Version [PDF - 294 KB - 5 pages]
    R. B. Tesh et al.
        View Abstract

    A proposed new small-animal (rodent) model for studying the pathogenesis and treatment of severe orthopoxvirus infections is described. Thirteen-lined ground squirrels (Spermophilus tridecemlineatus) were infected intraperitoneally and intranasally with monkeypox virus (MPXV). A fulminant illness developed in all animals, and they died 6–9 days after infection. Virus was cultured from the blood and oropharynx several days before death; at necropsy, all of the organs tested contained relatively high titers of MPXV. The major pathologic findings were in the liver, which showed centrilobular necrosis, steatosis, and basophilic inclusion bodies in hepatocytes. Splenic necrosis was also observed, as well as interstitial inflammation in the lungs. The pathologic features of MPXV in ground squirrels is similar to that described with MPXV in macaques and severe variola (smallpox) virus infection in humans.

        Cite This Article
    EID Tesh RB, Watts DM, Sbrana E, Siirin M, Popov VL, Xiao S, et al. Experimental Infection of Ground Squirrels (Spermophilus tridecemlineatus) with Monkeypox Virus. Emerg Infect Dis. 2004;10(9):1563-1567. https://dx.doi.org/10.3201/eid1009.040310
    AMA Tesh RB, Watts DM, Sbrana E, et al. Experimental Infection of Ground Squirrels (Spermophilus tridecemlineatus) with Monkeypox Virus. Emerging Infectious Diseases. 2004;10(9):1563-1567. doi:10.3201/eid1009.040310.
    APA Tesh, R. B., Watts, D. M., Sbrana, E., Siirin, M., Popov, V. L., & Xiao, S. (2004). Experimental Infection of Ground Squirrels (Spermophilus tridecemlineatus) with Monkeypox Virus. Emerging Infectious Diseases, 10(9), 1563-1567. https://dx.doi.org/10.3201/eid1009.040310.
        Email Email this Article
  • Silent Nucleotide Polymorphisms and a Phylogeny for Mycobacterium tuberculosis PDF Version [PDF - 309 KB - 10 pages]
    L. Baker et al.
        View Abstract

    Much remains unknown of the phylogeny and evolution of Mycobacterium tuberculosis, an organism that kills 2 million people annually. Using a population-based approach that analyzes multiple loci around the chromosome, we demonstrate that neutral genetic variation in genes associated with antimicrobial drug resistance has sufficient variation to construct a robust phylogenetic tree for M. tuberculosis. The data describe a clonal population with a minimum of four distinct M. tuberculosis lineages, closely related to M. bovis. The lineages are strongly geographically associated. Nucleotide substitutions proven to cause drug resistance are distributed throughout the tree, whereas nonsynonymous base substitutions unrelated to drug resistance have a restricted distribution. The phylogenetic structure is concordant with all the previously described genotypic and phenotypic groupings of M. tuberculosis strains and provides a unifying framework for both epidemiologic and evolutionary analysis of M. tuberculosis populations.

        Cite This Article
    EID Baker L, Brown T, Maiden M, Drobniewski F. Silent Nucleotide Polymorphisms and a Phylogeny for Mycobacterium tuberculosis. Emerg Infect Dis. 2004;10(9):1568-1577. https://dx.doi.org/10.3201/eid1009.040046
    AMA Baker L, Brown T, Maiden M, et al. Silent Nucleotide Polymorphisms and a Phylogeny for Mycobacterium tuberculosis. Emerging Infectious Diseases. 2004;10(9):1568-1577. doi:10.3201/eid1009.040046.
    APA Baker, L., Brown, T., Maiden, M., & Drobniewski, F. (2004). Silent Nucleotide Polymorphisms and a Phylogeny for Mycobacterium tuberculosis. Emerging Infectious Diseases, 10(9), 1568-1577. https://dx.doi.org/10.3201/eid1009.040046.
        Email Email this Article
  • Genetic Divergence and Dispersal of Yellow Fever Virus, Brazil PDF Version [PDF - 349 KB - 7 pages]
    P. Vasconcelos et al.
    View Summary

    Examining viral isolates collected over 66 years shows divergence into clades and potential dispersal by human migration.

        View Abstract

    An analysis of 79 yellow fever virus (YFV) isolates collected from 1935 to 2001 in Brazil showed a single genotype (South America I) circulating in the country, with the exception of a single strain from Rondônia, which represented South America genotype II. Brazilian YFV strains have diverged into two clades; an older clade appears to have become extinct and another has become the dominant lineage in recent years. Pairwise nucleotide diversity between strains ranged from 0% to 7.4%, while amino acid divergence ranged from 0% to 4.6%. Phylogenetic analysis indicated traffic of virus variants through large geographic areas and suggested that migration of infected people may be an important mechanism of virus dispersal. Isolation of vaccine virus from a patient with a fatal case suggests that vaccine-related illness may have been misdiagnosed in the past.

        Cite This Article
    EID Vasconcelos P, Bryant JE, Travassos da Rosa A, Tesh RB, Rodrigues SG, Barrett A, et al. Genetic Divergence and Dispersal of Yellow Fever Virus, Brazil. Emerg Infect Dis. 2004;10(9):1578-1584. https://dx.doi.org/10.3201/eid1009.040197
    AMA Vasconcelos P, Bryant JE, Travassos da Rosa A, et al. Genetic Divergence and Dispersal of Yellow Fever Virus, Brazil. Emerging Infectious Diseases. 2004;10(9):1578-1584. doi:10.3201/eid1009.040197.
    APA Vasconcelos, P., Bryant, J. E., Travassos da Rosa, A., Tesh, R. B., Rodrigues, S. G., & Barrett, A. (2004). Genetic Divergence and Dispersal of Yellow Fever Virus, Brazil. Emerging Infectious Diseases, 10(9), 1578-1584. https://dx.doi.org/10.3201/eid1009.040197.
        Email Email this Article
  • Rotavirus Serotype G9P[8] and Acute Gastroenteritis Outbreak in Children, Northern Australia PDF Version [PDF - 168 KB - 8 pages]
    C. D. Kirkwood et al.
        View Abstract

    During 2001, an outbreak of severe acute gastroenteritis swept through Central and northern Australia and caused serious disruption to health services. We tracked and characterized the rotavirus strain implicated in the outbreak. Comparison of the electropherotypes of outbreak samples suggested that one G9P[8] strain was likely responsible for the outbreak. Samples were obtained from geographically distinct regions of Australia where the epidemic had occurred. The outbreak strains showed identical nucleotide sequences in genes encoding three rotavirus proteins, VP7, VP8, and NSP4, but they were distinct from G9P[8] strains isolated in previous years. Several of the amino acid substitutions on the VP7 and NSP4 proteins were identified in regions known to influence function and may have contributed to the emergence and increased dominance of the outbreak strains. Rotavirus serotype surveillance should continue with methods capable of identifying new and emerging types.

        Cite This Article
    EID Kirkwood CD, Bogdanovic-Sakran N, Barnes G, Bishop R. Rotavirus Serotype G9P[8] and Acute Gastroenteritis Outbreak in Children, Northern Australia. Emerg Infect Dis. 2004;10(9):1593-1600. https://dx.doi.org/10.3201/eid1009.040040
    AMA Kirkwood CD, Bogdanovic-Sakran N, Barnes G, et al. Rotavirus Serotype G9P[8] and Acute Gastroenteritis Outbreak in Children, Northern Australia. Emerging Infectious Diseases. 2004;10(9):1593-1600. doi:10.3201/eid1009.040040.
    APA Kirkwood, C. D., Bogdanovic-Sakran, N., Barnes, G., & Bishop, R. (2004). Rotavirus Serotype G9P[8] and Acute Gastroenteritis Outbreak in Children, Northern Australia. Emerging Infectious Diseases, 10(9), 1593-1600. https://dx.doi.org/10.3201/eid1009.040040.
        Email Email this Article
  • Foodborne Botulism in the Republic of Georgia PDF Version [PDF - 182 KB - 5 pages]
    J. K. Varma et al.
        View Abstract

    Foodborne botulism is a potentially fatal, paralytic illness that can cause large outbreaks. A possible increase in botulism incidence during 2001 in Georgia prompted this study. We reviewed surveillance data and abstracted records of patients with botulism who were hospitalized from 1980 to 2002. During this period, 879 botulism cases were detected. The median annual incidence increased from 0.3 per 100,000 during 1980 to 1990 to 0.9 per 100,000 during 1991 to 2002. For 706 botulism patients hospitalized from 1980 to 2002, 80% of their cases were attributed to home-preserved vegetables. Surveillance evaluation verified that botulism incidence varied greatly by region. Georgia has the highest nationally reported rate of foodborne botulism in the world. A strategy addressing individual behaviors in the home is needed to improve food safety; developing this strategy requires a deeper understanding of why botulism has increased and varies by region.

        Cite This Article
    EID Varma JK, Katsitadze G, Moiscrafishvili M, Zardiashvili T, Chokheli M, Tarkhashvili N, et al. Foodborne Botulism in the Republic of Georgia. Emerg Infect Dis. 2004;10(9):1601-1605. https://dx.doi.org/10.3201/eid1009.030806
    AMA Varma JK, Katsitadze G, Moiscrafishvili M, et al. Foodborne Botulism in the Republic of Georgia. Emerging Infectious Diseases. 2004;10(9):1601-1605. doi:10.3201/eid1009.030806.
    APA Varma, J. K., Katsitadze, G., Moiscrafishvili, M., Zardiashvili, T., Chokheli, M., Tarkhashvili, N....Sobel, J. (2004). Foodborne Botulism in the Republic of Georgia. Emerging Infectious Diseases, 10(9), 1601-1605. https://dx.doi.org/10.3201/eid1009.030806.
        Email Email this Article
  • Foodborne Botulism in the United States, 1990–2000 PDF Version [PDF - 67 KB - 6 pages]
    J. Sobel et al.
        View Abstract

    Foodborne botulism, a potentially lethal neuroparalytic disease, is caused by ingesting preformed Clostridium botulinum neurotoxin. We reviewed surveillance data and reports from 1990 to 2000. Of 263 cases from 160 foodborne botulism events (episode of one or more related cases) in the United States, 103 (39%) cases and 58 events occurred in Alaska. Patients’ median age was 48 years; 154 (59%) were female; the case-fatality rate was 4%. The median number of cases per event was 1 (range 1–17). Toxin type A caused 51% of all cases; toxin type E caused 90% of Alaska cases. A particular food was implicated in 126 (79%) events. In the lower 49 states, a noncommercial food item was implicated in 70 (91%) events, most commonly, home-canned vegetables (44%). Two restaurant-associated outbreaks affected 25 persons. All Alaska cases were attributable to traditional Alaska Native foods. Botulism prevention efforts should be focused on those who preserve food at home, Alaska Natives, and restaurant workers.

        Cite This Article
    EID Sobel J, Tucker N, Sulka A, McLaughlin J, Maslanka S. Foodborne Botulism in the United States, 1990–2000. Emerg Infect Dis. 2004;10(9):1606-1611. https://dx.doi.org/10.3201/eid1009.030745
    AMA Sobel J, Tucker N, Sulka A, et al. Foodborne Botulism in the United States, 1990–2000. Emerging Infectious Diseases. 2004;10(9):1606-1611. doi:10.3201/eid1009.030745.
    APA Sobel, J., Tucker, N., Sulka, A., McLaughlin, J., & Maslanka, S. (2004). Foodborne Botulism in the United States, 1990–2000. Emerging Infectious Diseases, 10(9), 1606-1611. https://dx.doi.org/10.3201/eid1009.030745.
        Email Email this Article
  • Computer Algorithms To Detect Bloodstream Infections PDF Version [PDF - 285 KB - 9 pages]
    W. E. Trick et al.
        View Abstract

    We compared manual and computer-assisted bloodstream infection surveillance for adult inpatients at two hospitals. We identified hospital-acquired, primary, central-venous catheter (CVC)-associated bloodstream infections by using five methods: retrospective, manual record review by investigators; prospective, manual review by infection control professionals; positive blood culture plus manual CVC determination; computer algorithms; and computer algorithms and manual CVC determination. We calculated sensitivity, specificity, predictive values, plus the kappa statistic (κ) between investigator review and other methods, and we correlated infection rates for seven units. The κ value was 0.37 for infection control review, 0.48 for positive blood culture plus manual CVC determination, 0.49 for computer algorithm, and 0.73 for computer algorithm plus manual CVC determination. Unit-specific infection rates, per 1,000 patient days, were 1.0–12.5 by investigator review and 1.4–10.2 by computer algorithm (correlation r = 0.91, p = 0.004). Automated bloodstream infection surveillance with electronic data is an accurate alternative to surveillance with manually collected data.

        Cite This Article
    EID Trick WE, Zagorski BM, Tokars JI, Vernon MO, Welbel SF, Wisniewski MF, et al. Computer Algorithms To Detect Bloodstream Infections. Emerg Infect Dis. 2004;10(9):1612-1620. https://dx.doi.org/10.3201/eid1009.030978
    AMA Trick WE, Zagorski BM, Tokars JI, et al. Computer Algorithms To Detect Bloodstream Infections. Emerging Infectious Diseases. 2004;10(9):1612-1620. doi:10.3201/eid1009.030978.
    APA Trick, W. E., Zagorski, B. M., Tokars, J. I., Vernon, M. O., Welbel, S. F., Wisniewski, M. F....Weinstein, R. A. (2004). Computer Algorithms To Detect Bloodstream Infections. Emerging Infectious Diseases, 10(9), 1612-1620. https://dx.doi.org/10.3201/eid1009.030978.
        Email Email this Article
  • Space-Time Cluster Analysis of Invasive Meningococcal Disease PDF Version [PDF - 98 KB - 6 pages]
    C. J. Hoebe et al.
        View Abstract

    Clusters are recognized when meningococcal cases of the same phenotypic strain (markers: serogroup, serotype, and subtype) occur in spatial and temporal proximity. The incidence of such clusters was compared to the incidence that would be expected by chance by using space-time nearest-neighbor analysis of 4,887 confirmed invasive meningococcal cases identified in the 9-year surveillance period 1993–2001 in the Netherlands. Clustering beyond chance only occurred among the closest neighboring cases (comparable to secondary cases) and was small (3.1%, 95% confidence interval 2.1%–4.1%).

        Cite This Article
    EID Hoebe CJ, de Melker HE, Spanjaard L, Dankert J, Nagelkerke N. Space-Time Cluster Analysis of Invasive Meningococcal Disease. Emerg Infect Dis. 2004;10(9):1621-1626. https://dx.doi.org/10.3201/eid1009.030992
    AMA Hoebe CJ, de Melker HE, Spanjaard L, et al. Space-Time Cluster Analysis of Invasive Meningococcal Disease. Emerging Infectious Diseases. 2004;10(9):1621-1626. doi:10.3201/eid1009.030992.
    APA Hoebe, C. J., de Melker, H. E., Spanjaard, L., Dankert, J., & Nagelkerke, N. (2004). Space-Time Cluster Analysis of Invasive Meningococcal Disease. Emerging Infectious Diseases, 10(9), 1621-1626. https://dx.doi.org/10.3201/eid1009.030992.
        Email Email this Article
  • Methicillin-resistant Staphylococcus aureus in Europe, 1999–2002 PDF Version [PDF - 158 KB - 8 pages]
    E. W. Tiemersma et al.
        View Abstract

    We explored the variation in proportions of methicillin-resistant Staphylococcus aureus (MRSA) between and within countries participating in the European Antimicrobial Resistance Surveillance System and temporal trends in its occurrence. This system collects routine antimicrobial susceptibility tests for S. aureus. We examined data collected from January 1999 through December 2002 (50,759 isolates from 495 hospitals in 26 countries). MRSA prevalence varied almost 100-fold, from <1% in northern Europe to >40% in southern and western Europe. MRSA proportions significantly increased in Belgium, Germany, Ireland, the Netherlands, and the United Kingdom, and decreased in Slovenia. Within countries, MRSA proportions varied between hospitals with highest variance in countries with a prevalence of 5% to 20%. The observed trends should stimulate initiatives to control MRSA at national, regional, and hospital levels. The large differences between hospitals indicate that efforts may be most effective at regional and hospital levels.

        Cite This Article
    EID Tiemersma EW, Bronzwaer SL, Lyytikäinen O, Degener JE, Schrijnemakers P, Bruinsma N, et al. Methicillin-resistant Staphylococcus aureus in Europe, 1999–2002. Emerg Infect Dis. 2004;10(9):1627-1634. https://dx.doi.org/10.3201/eid1009.040069
    AMA Tiemersma EW, Bronzwaer SL, Lyytikäinen O, et al. Methicillin-resistant Staphylococcus aureus in Europe, 1999–2002. Emerging Infectious Diseases. 2004;10(9):1627-1634. doi:10.3201/eid1009.040069.
    APA Tiemersma, E. W., Bronzwaer, S. L., Lyytikäinen, O., Degener, J. E., Schrijnemakers, P., Bruinsma, N....Grundmann, H. (2004). Methicillin-resistant Staphylococcus aureus in Europe, 1999–2002. Emerging Infectious Diseases, 10(9), 1627-1634. https://dx.doi.org/10.3201/eid1009.040069.
        Email Email this Article
  • Outbreak of Hantavirus Pulmonary Syndrome, Los Santos, Panama, 1999–2000 PDF Version [PDF - 118 KB - 8 pages]
    V. Bayard et al.
        View Abstract

    An outbreak of hantavirus pulmonary syndrome occurred in the province of Los Santos, Panama, in late 1999 and early 2000. Eleven cases were identified; 9 were confirmed by serology. Three cases were fatal; however, no confirmed case-patient died. Case-neighborhood serologic surveys resulted in an overall hantavirus antibody prevalence of 13% among household and neighborhood members from the outbreak foci. Epidemiologic investigations did not suggest person-to-person transmission of hantavirus infection. By use of Sin Nombre virus antigen, hantavirus antibodies were detected in Oligoryzomys fulvescens and Zygodontomys brevicauda cherriei. This outbreak resulted in the first documented cases of human hantavirus infections in Central America.

        Cite This Article
    EID Bayard V, Kitsutani PT, Barria EO, Ruedas LA, Tinnin DS, Muñoz C, et al. Outbreak of Hantavirus Pulmonary Syndrome, Los Santos, Panama, 1999–2000. Emerg Infect Dis. 2004;10(9):1635-1642. https://dx.doi.org/10.3201/eid1009.040143
    AMA Bayard V, Kitsutani PT, Barria EO, et al. Outbreak of Hantavirus Pulmonary Syndrome, Los Santos, Panama, 1999–2000. Emerging Infectious Diseases. 2004;10(9):1635-1642. doi:10.3201/eid1009.040143.
    APA Bayard, V., Kitsutani, P. T., Barria, E. O., Ruedas, L. A., Tinnin, D. S., Muñoz, C....Peters, C. J. (2004). Outbreak of Hantavirus Pulmonary Syndrome, Los Santos, Panama, 1999–2000. Emerging Infectious Diseases, 10(9), 1635-1642. https://dx.doi.org/10.3201/eid1009.040143.
        Email Email this Article
  • Detection of Anaplasma phagocytophilum DNA in Ixodes Ticks (Acari: Ixodidae) from Madeira Island and Setúbal District, Mainland Portugal PDF Version [PDF - 203 KB - 6 pages]
    A. S. Santos et al.
        View Abstract

    A total of 278 Ixodes ticks, collected from Madeira Island and Setúbal District, mainland Portugal, were examined by polymerase chain reaction (PCR) for the presence of Anaplasma phagocytophilum. Six (4%) of 142 Ixodes ricinus nymphs collected in Madeira Island, and 1 nymph and 1 male (2%) of 93 I. ventalloi collected in Setúbal District tested positive for A. phagocytophilum msp2 genes or rrs. Infection was not detected among 43 I. ricinus on mainland Portugal. All PCR products were confirmed by nucleotide sequencing to be identical or to be most closely related to A. phagocytophilum. To our knowledge, this is the first evidence of A. phagocytophilum in ticks from Setúbal District, mainland Portugal, and the first documentation of Anaplasma infection in I. ventalloi. Moreover, these findings confirm the persistence of A. phagocytophilum in Madeira Island’s I. ricinus.

        Cite This Article
    EID Santos AS, Santos-Silva MM, Almeida VC, Bacellar F, Dumler JS. Detection of Anaplasma phagocytophilum DNA in Ixodes Ticks (Acari: Ixodidae) from Madeira Island and Setúbal District, Mainland Portugal. Emerg Infect Dis. 2004;10(9):1643-1648. https://dx.doi.org/10.3201/eid1009.040276
    AMA Santos AS, Santos-Silva MM, Almeida VC, et al. Detection of Anaplasma phagocytophilum DNA in Ixodes Ticks (Acari: Ixodidae) from Madeira Island and Setúbal District, Mainland Portugal. Emerging Infectious Diseases. 2004;10(9):1643-1648. doi:10.3201/eid1009.040276.
    APA Santos, A. S., Santos-Silva, M. M., Almeida, V. C., Bacellar, F., & Dumler, J. S. (2004). Detection of Anaplasma phagocytophilum DNA in Ixodes Ticks (Acari: Ixodidae) from Madeira Island and Setúbal District, Mainland Portugal. Emerging Infectious Diseases, 10(9), 1643-1648. https://dx.doi.org/10.3201/eid1009.040276.
        Email Email this Article
  • Genotyping, Orientalis-like Yersinia pestis, and Plague Pandemics PDF Version [PDF - 176 KB - 8 pages]
    M. Drancourt et al.
    View Summary

    Two historical plague pandemics were likely caused by Orientalis-like strains of Yersinia pestis.

        View Abstract

    Three pandemics have been attributed to plague in the last 1,500 years. Yersinia pestis caused the third, and its DNA was found in human remains from the second. The Antiqua biovar of Y. pestis may have caused the first pandemic; the other two biovars, Medievalis and Orientalis, may have caused the second and third pandemics, respectively. To test this hypothesis, we designed an original genotyping system based on intergenic spacer sequencing called multiple spacer typing (MST). We found that MST differentiated every biovar in a collection of 36 Y. pestis isolates representative of the three biovars. When MST was applied to dental pulp collected from remains of eight persons who likely died in the first and second pandemics, this system identified original sequences that matched those of Y. pestis Orientalis. These data indicate that Y. pestis caused cases of Justinian plague. The two historical plague pandemics were likely caused by Orientalis-like strains.

        Cite This Article
    EID Drancourt M, Roux V, Dang L, Tran-Hung L, Castex D, Chenal-Francisque V, et al. Genotyping, Orientalis-like Yersinia pestis, and Plague Pandemics. Emerg Infect Dis. 2004;10(9):1585-1592. https://dx.doi.org/10.3201/eid1009.030933
    AMA Drancourt M, Roux V, Dang L, et al. Genotyping, Orientalis-like Yersinia pestis, and Plague Pandemics. Emerging Infectious Diseases. 2004;10(9):1585-1592. doi:10.3201/eid1009.030933.
    APA Drancourt, M., Roux, V., Dang, L., Tran-Hung, L., Castex, D., Chenal-Francisque, V....Raoult, D. (2004). Genotyping, Orientalis-like Yersinia pestis, and Plague Pandemics. Emerging Infectious Diseases, 10(9), 1585-1592. https://dx.doi.org/10.3201/eid1009.030933.
        Email Email this Article

Dispatches

  • Year-round West Nile Virus Activity, Gulf Coast Region, Texas and Louisiana PDF Version [PDF - 99 KB - 4 pages]
    R. B. Tesh et al.
        View Abstract

    West Nile virus (WNV) was detected in 11 dead birds and two mosquito pools collected in east Texas and southern Louisiana during surveillance studies in the winter of 2003 to 2004. These findings suggest that WNV is active throughout the year in this region of the United States.

        Cite This Article
    EID Tesh RB, Parsons R, Siirin M, Randle Y, Sargent C, Guzman H, et al. Year-round West Nile Virus Activity, Gulf Coast Region, Texas and Louisiana. Emerg Infect Dis. 2004;10(9):1649-1652. https://dx.doi.org/10.3201/eid1009.040203
    AMA Tesh RB, Parsons R, Siirin M, et al. Year-round West Nile Virus Activity, Gulf Coast Region, Texas and Louisiana. Emerging Infectious Diseases. 2004;10(9):1649-1652. doi:10.3201/eid1009.040203.
    APA Tesh, R. B., Parsons, R., Siirin, M., Randle, Y., Sargent, C., Guzman, H....Zerinque, B. (2004). Year-round West Nile Virus Activity, Gulf Coast Region, Texas and Louisiana. Emerging Infectious Diseases, 10(9), 1649-1652. https://dx.doi.org/10.3201/eid1009.040203.
        Email Email this Article
  • SARS-CoV Antibody Prevalence in All Hong Kong Patient Contacts PDF Version [PDF - 139 KB - 4 pages]
    G. M. Leung et al.
        View Abstract

    A total of 1,068 asymptomatic close contacts of patients with severe acute respiratory (SARS) from the 2003 epidemic in Hong Kong were serologically tested, and 2 (0.19%) were positive for SARS coronavirus immunoglobulin G antibody. SARS rarely manifests as a subclinical infection, and at present, wild animal species are the only important natural reservoirs of the virus.

        Cite This Article
    EID Leung GM, Chung P, Tsang T, Lim W, Chan SK, Chau P, et al. SARS-CoV Antibody Prevalence in All Hong Kong Patient Contacts. Emerg Infect Dis. 2004;10(9):1653-1656. https://dx.doi.org/10.3201/eid1009.040155
    AMA Leung GM, Chung P, Tsang T, et al. SARS-CoV Antibody Prevalence in All Hong Kong Patient Contacts. Emerging Infectious Diseases. 2004;10(9):1653-1656. doi:10.3201/eid1009.040155.
    APA Leung, G. M., Chung, P., Tsang, T., Lim, W., Chan, S. K., Chau, P....Hedley, A. J. (2004). SARS-CoV Antibody Prevalence in All Hong Kong Patient Contacts. Emerging Infectious Diseases, 10(9), 1653-1656. https://dx.doi.org/10.3201/eid1009.040155.
        Email Email this Article
  • Yellow Fever Virus Infectivity for Bolivian Aedes aegypti Mosquitoes PDF Version [PDF - 148 KB - 4 pages]
    J. Mutebi et al.
        View Abstract

    The absence of urban yellow fever virus (YFV) in Bolivian cities has been attributed to the lack of competent urban mosquito vectors. Experiments with Aedes aegypti from Santa Cruz, Bolivia, demonstrated infection (100%), dissemination (20%), and transmission of a Bolivian YVF strain (CENETROP-322).

        Cite This Article
    EID Mutebi J, Gianella A, Travassos da Rosa A, Tesh RB, Barrett AD, Higgs S, et al. Yellow Fever Virus Infectivity for Bolivian Aedes aegypti Mosquitoes. Emerg Infect Dis. 2004;10(9):1657-1660. https://dx.doi.org/10.3201/eid1009.031124
    AMA Mutebi J, Gianella A, Travassos da Rosa A, et al. Yellow Fever Virus Infectivity for Bolivian Aedes aegypti Mosquitoes. Emerging Infectious Diseases. 2004;10(9):1657-1660. doi:10.3201/eid1009.031124.
    APA Mutebi, J., Gianella, A., Travassos da Rosa, A., Tesh, R. B., Barrett, A. D., & Higgs, S. (2004). Yellow Fever Virus Infectivity for Bolivian Aedes aegypti Mosquitoes. Emerging Infectious Diseases, 10(9), 1657-1660. https://dx.doi.org/10.3201/eid1009.031124.
        Email Email this Article
  • Typing of Borrelia Relapsing Fever Group Strains PDF Version [PDF - 110 KB - 4 pages]
    J. Bunikis et al.
        View Abstract

    Partial sequencing of the 16S-23S rDNA intergenic spacer showed two to four genotypes each for Borrelia hermsii and B. turicatae, both relapsing fever agents transmitted by argasid ticks, and for B. miyamotoi and B. lonestari, transmitted by ixodid ticks. Field surveys of Ixodes ticks in Connecticut and Sweden showed limited local diversity for B. miyamotoi.

        Cite This Article
    EID Bunikis J, Tsao JI, Garpmo U, Berglund J, Fish D, Barbour AG, et al. Typing of Borrelia Relapsing Fever Group Strains. Emerg Infect Dis. 2004;10(9):1661-1664. https://dx.doi.org/10.3201/eid1009.040236
    AMA Bunikis J, Tsao JI, Garpmo U, et al. Typing of Borrelia Relapsing Fever Group Strains. Emerging Infectious Diseases. 2004;10(9):1661-1664. doi:10.3201/eid1009.040236.
    APA Bunikis, J., Tsao, J. I., Garpmo, U., Berglund, J., Fish, D., & Barbour, A. G. (2004). Typing of Borrelia Relapsing Fever Group Strains. Emerging Infectious Diseases, 10(9), 1661-1664. https://dx.doi.org/10.3201/eid1009.040236.
        Email Email this Article
  • Salmonella enterica Serotype Uganda Infection in New York City and Chicago PDF Version [PDF - 94 KB - 3 pages]
    R. C. Jones et al.
        View Abstract

    Outbreaks associated with distinct strains of Salmonella enterica serotype Uganda, a rare serotype, occurred in New York City and Chicago during the summer of 2001. Both outbreaks were linked to eating ready-to-eat pork products. This serotype may emerge as a more frequent cause of human infections.

        Cite This Article
    EID Jones RC, Reddy V, Kornstein L, Fernandez JR, Stavinsky F, Agasan A, et al. Salmonella enterica Serotype Uganda Infection in New York City and Chicago. Emerg Infect Dis. 2004;10(9):1665-1667. https://dx.doi.org/10.3201/eid1009.030713
    AMA Jones RC, Reddy V, Kornstein L, et al. Salmonella enterica Serotype Uganda Infection in New York City and Chicago. Emerging Infectious Diseases. 2004;10(9):1665-1667. doi:10.3201/eid1009.030713.
    APA Jones, R. C., Reddy, V., Kornstein, L., Fernandez, J. R., Stavinsky, F., Agasan, A....Gerber, S. I. (2004). Salmonella enterica Serotype Uganda Infection in New York City and Chicago. Emerging Infectious Diseases, 10(9), 1665-1667. https://dx.doi.org/10.3201/eid1009.030713.
        Email Email this Article
  • Yellow Fever Outbreak, Southern Sudan, 2003 PDF Version [PDF - 75 KB - 3 pages]
    C. O. Onyango et al.
        View Abstract

    In May 2003, an outbreak of fatal hemorrhagic fever, caused by yellow fever virus, occurred in southern Sudan. Phylogenetic analysis showed that the virus belonged to the East African genotype, which supports the contention that yellow fever is endemic in East Africa with the potential to cause large outbreaks in humans.

        Cite This Article
    EID Onyango CO, Grobbelaar AA, Gibson GV, Sang RC, Sow A, Swanepoel R, et al. Yellow Fever Outbreak, Southern Sudan, 2003. Emerg Infect Dis. 2004;10(9):1668-1670. https://dx.doi.org/10.3201/eid1009.030727
    AMA Onyango CO, Grobbelaar AA, Gibson GV, et al. Yellow Fever Outbreak, Southern Sudan, 2003. Emerging Infectious Diseases. 2004;10(9):1668-1670. doi:10.3201/eid1009.030727.
    APA Onyango, C. O., Grobbelaar, A. A., Gibson, G. V., Sang, R. C., Sow, A., Swanepoel, R....Burt, F. J. (2004). Yellow Fever Outbreak, Southern Sudan, 2003. Emerging Infectious Diseases, 10(9), 1668-1670. https://dx.doi.org/10.3201/eid1009.030727.
        Email Email this Article
  • Acinetobacter baumannii in Human Body Louse PDF Version [PDF - 99 KB - 3 pages]
    B. La Scola and D. Raoult
        View Abstract

    While we were isolating Bartonella quintana from body lice, 40 Acinetobacter baumannii strains were also isolated and genotyped. One clone was unique and the other was ampicillin susceptible. A. baumannii DNA was later detected in 21% of 622 lice collected worldwide. These findings show an A. baumannii epidemic in human body lice.

        Cite This Article
    EID La Scola B, Raoult D. Acinetobacter baumannii in Human Body Louse. Emerg Infect Dis. 2004;10(9):1671-1673. https://dx.doi.org/10.3201/eid1009.040242
    AMA La Scola B, Raoult D. Acinetobacter baumannii in Human Body Louse. Emerging Infectious Diseases. 2004;10(9):1671-1673. doi:10.3201/eid1009.040242.
    APA La Scola, B., & Raoult, D. (2004). Acinetobacter baumannii in Human Body Louse. Emerging Infectious Diseases, 10(9), 1671-1673. https://dx.doi.org/10.3201/eid1009.040242.
        Email Email this Article
  • Fluoroquinolone Resistance in Salmonella enterica Serotype Choleraesuis, Taiwan, 2000–2003 PDF Version [PDF - 119 KB - 3 pages]
    C. Chiu et al.
        View Abstract

    Salmonella enterica serotype Choleraesuis is a highly invasive pathogen that infects humans and causes systemic infections that require antimicrobial therapy. Surveillance in Taiwan showed that fluoroquinolone resistance in S. Choleraesuis markedly increased from 2000 to 2003, reaching approximately 70% in 2003.

        Cite This Article
    EID Chiu C, Wu T, Su L, Liu J, Chu C. Fluoroquinolone Resistance in Salmonella enterica Serotype Choleraesuis, Taiwan, 2000–2003. Emerg Infect Dis. 2004;10(9):1674-1676. https://dx.doi.org/10.3201/eid1009.030596
    AMA Chiu C, Wu T, Su L, et al. Fluoroquinolone Resistance in Salmonella enterica Serotype Choleraesuis, Taiwan, 2000–2003. Emerging Infectious Diseases. 2004;10(9):1674-1676. doi:10.3201/eid1009.030596.
    APA Chiu, C., Wu, T., Su, L., Liu, J., & Chu, C. (2004). Fluoroquinolone Resistance in Salmonella enterica Serotype Choleraesuis, Taiwan, 2000–2003. Emerging Infectious Diseases, 10(9), 1674-1676. https://dx.doi.org/10.3201/eid1009.030596.
        Email Email this Article
  • Barriers to Creutzfeldt-Jakob Disease Autopsies, California PDF Version [PDF - 160 KB - 4 pages]
    J. K. Louie et al.
        View Abstract

    Creutzfeldt-Jakob disease (CJD) surveillance relies on autopsy and neuropathologic evaluation. The 1990–2000 CJD autopsy rate in California was 21%. Most neurologists were comfortable diagnosing CJD (83%), but few pathologists felt comfortable diagnosing CJD (35%) or performing autopsy (29%). Addressing obstacles to autopsy is necessary to improve CJD surveillance.

        Cite This Article
    EID Louie JK, Gavali SS, Belay ED, Trevejo R, Hammond LH, Schonberger LB, et al. Barriers to Creutzfeldt-Jakob Disease Autopsies, California. Emerg Infect Dis. 2004;10(9):1677-1680. https://dx.doi.org/10.3201/eid1009.040066
    AMA Louie JK, Gavali SS, Belay ED, et al. Barriers to Creutzfeldt-Jakob Disease Autopsies, California. Emerging Infectious Diseases. 2004;10(9):1677-1680. doi:10.3201/eid1009.040066.
    APA Louie, J. K., Gavali, S. S., Belay, E. D., Trevejo, R., Hammond, L. H., Schonberger, L. B....Vugia, D. J. (2004). Barriers to Creutzfeldt-Jakob Disease Autopsies, California. Emerging Infectious Diseases, 10(9), 1677-1680. https://dx.doi.org/10.3201/eid1009.040066.
        Email Email this Article
  • Leishmaniasis in Refugee and Local Pakistani Populations PDF Version [PDF - 95 KB - 4 pages]
    S. Brooker et al.
        View Abstract

    The epidemiology of anthroponotic cutaneous leishmaniasis was investigated in northwest Pakistan. Results suggested similar patterns of endemicity in both Afghan refugee and Pakistani populations and highlighted risk factors and household clustering of disease.

        Cite This Article
    EID Brooker S, Mohammed N, Adil K, Agha S, Reithinger R, Rowland M, et al. Leishmaniasis in Refugee and Local Pakistani Populations. Emerg Infect Dis. 2004;10(9):1681-1684. https://dx.doi.org/10.3201/eid1009.040179
    AMA Brooker S, Mohammed N, Adil K, et al. Leishmaniasis in Refugee and Local Pakistani Populations. Emerging Infectious Diseases. 2004;10(9):1681-1684. doi:10.3201/eid1009.040179.
    APA Brooker, S., Mohammed, N., Adil, K., Agha, S., Reithinger, R., Rowland, M....Kolaczinski, J. (2004). Leishmaniasis in Refugee and Local Pakistani Populations. Emerging Infectious Diseases, 10(9), 1681-1684. https://dx.doi.org/10.3201/eid1009.040179.
        Email Email this Article
  • Botulism Type E Outbreak Associated with Eating a Beached Whale, Alaska PDF Version [PDF - 626 KB - 3 pages]
    J. B. Mclaughlin et al.
        View Abstract

    We report an outbreak of botulism that occurred in July 2002 in a group of 12 Alaskan Yu’pik Eskimos who ate blubber and skin from a beached beluga whale. Botulism death rates among Alaska Natives have declined in the last 20 years, yet incidence has increased.

        Cite This Article
    EID Mclaughlin JB, Sobel J, Lynn T, Funk E, Middaugh JP. Botulism Type E Outbreak Associated with Eating a Beached Whale, Alaska. Emerg Infect Dis. 2004;10(9):1685-1687. https://dx.doi.org/10.3201/eid1009.040131
    AMA Mclaughlin JB, Sobel J, Lynn T, et al. Botulism Type E Outbreak Associated with Eating a Beached Whale, Alaska. Emerging Infectious Diseases. 2004;10(9):1685-1687. doi:10.3201/eid1009.040131.
    APA Mclaughlin, J. B., Sobel, J., Lynn, T., Funk, E., & Middaugh, J. P. (2004). Botulism Type E Outbreak Associated with Eating a Beached Whale, Alaska. Emerging Infectious Diseases, 10(9), 1685-1687. https://dx.doi.org/10.3201/eid1009.040131.
        Email Email this Article

Letters

  • Toronto Emergency Medical Services and SARS PDF Version [PDF - 23 KB - 2 pages]
    A. Silverman et al.
            Cite This Article
    EID Silverman A, Simor A, Loutfy MR. Toronto Emergency Medical Services and SARS. Emerg Infect Dis. 2004;10(9):1688-1689. https://dx.doi.org/10.3201/eid1009.040170
    AMA Silverman A, Simor A, Loutfy MR. Toronto Emergency Medical Services and SARS. Emerging Infectious Diseases. 2004;10(9):1688-1689. doi:10.3201/eid1009.040170.
    APA Silverman, A., Simor, A., & Loutfy, M. R. (2004). Toronto Emergency Medical Services and SARS. Emerging Infectious Diseases, 10(9), 1688-1689. https://dx.doi.org/10.3201/eid1009.040170.
        Email Email this Article
  • SARS during Pregnancy, United States PDF Version [PDF - 22 KB - 2 pages]
    L. A. Stockman et al.
            Cite This Article
    EID Stockman LA, Lowther SA, Coy K, Saw J, Parashar UD. SARS during Pregnancy, United States. Emerg Infect Dis. 2004;10(9):1689-1690. https://dx.doi.org/10.3201/eid1009.040244
    AMA Stockman LA, Lowther SA, Coy K, et al. SARS during Pregnancy, United States. Emerging Infectious Diseases. 2004;10(9):1689-1690. doi:10.3201/eid1009.040244.
    APA Stockman, L. A., Lowther, S. A., Coy, K., Saw, J., & Parashar, U. D. (2004). SARS during Pregnancy, United States. Emerging Infectious Diseases, 10(9), 1689-1690. https://dx.doi.org/10.3201/eid1009.040244.
        Email Email this Article
  • Eosinophilic Pleural Effusion in Gnathostomiasis PDF Version [PDF - 25 KB - 2 pages]
    P. Parola et al.
            Cite This Article
    EID Parola P, Bordmann G, Brouqui P, Delmont J. Eosinophilic Pleural Effusion in Gnathostomiasis. Emerg Infect Dis. 2004;10(9):1690-1691. https://dx.doi.org/10.3201/eid1009.030671
    AMA Parola P, Bordmann G, Brouqui P, et al. Eosinophilic Pleural Effusion in Gnathostomiasis. Emerging Infectious Diseases. 2004;10(9):1690-1691. doi:10.3201/eid1009.030671.
    APA Parola, P., Bordmann, G., Brouqui, P., & Delmont, J. (2004). Eosinophilic Pleural Effusion in Gnathostomiasis. Emerging Infectious Diseases, 10(9), 1690-1691. https://dx.doi.org/10.3201/eid1009.030671.
        Email Email this Article
  • Methicillin-resistant Staphylococcus aureus, Pakistan, 1996–2003 PDF Version [PDF - 25 KB - 2 pages]
    T. Butt et al.
            Cite This Article
    EID Butt T, Ahmad RN, Usman M, Mahmood A. Methicillin-resistant Staphylococcus aureus, Pakistan, 1996–2003. Emerg Infect Dis. 2004;10(9):1691-1692. https://dx.doi.org/10.3201/eid1009.030844
    AMA Butt T, Ahmad RN, Usman M, et al. Methicillin-resistant Staphylococcus aureus, Pakistan, 1996–2003. Emerging Infectious Diseases. 2004;10(9):1691-1692. doi:10.3201/eid1009.030844.
    APA Butt, T., Ahmad, R. N., Usman, M., & Mahmood, A. (2004). Methicillin-resistant Staphylococcus aureus, Pakistan, 1996–2003. Emerging Infectious Diseases, 10(9), 1691-1692. https://dx.doi.org/10.3201/eid1009.030844.
        Email Email this Article
  • Borrelia valaisiana in Cerebrospinal Fluid PDF Version [PDF - 24 KB - 2 pages]
    E. Diza et al.
            Cite This Article
    EID Diza E, Papa A, Vezyri E, Tsounis S, Milonas I, Antoniadis A, et al. Borrelia valaisiana in Cerebrospinal Fluid. Emerg Infect Dis. 2004;10(9):1692-1693. https://dx.doi.org/10.3201/eid1009.030439
    AMA Diza E, Papa A, Vezyri E, et al. Borrelia valaisiana in Cerebrospinal Fluid. Emerging Infectious Diseases. 2004;10(9):1692-1693. doi:10.3201/eid1009.030439.
    APA Diza, E., Papa, A., Vezyri, E., Tsounis, S., Milonas, I., & Antoniadis, A. (2004). Borrelia valaisiana in Cerebrospinal Fluid. Emerging Infectious Diseases, 10(9), 1692-1693. https://dx.doi.org/10.3201/eid1009.030439.
        Email Email this Article
  • Baylisascaris procyonis in California PDF Version [PDF - 26 KB - 2 pages]
    L. Moore et al.
            Cite This Article
    EID Moore L, Ash L, Sorvillo FJ, Berlin O. Baylisascaris procyonis in California. Emerg Infect Dis. 2004;10(9):1693-1694. https://dx.doi.org/10.3201/eid1009.040034
    AMA Moore L, Ash L, Sorvillo FJ, et al. Baylisascaris procyonis in California. Emerging Infectious Diseases. 2004;10(9):1693-1694. doi:10.3201/eid1009.040034.
    APA Moore, L., Ash, L., Sorvillo, F. J., & Berlin, O. (2004). Baylisascaris procyonis in California. Emerging Infectious Diseases, 10(9), 1693-1694. https://dx.doi.org/10.3201/eid1009.040034.
        Email Email this Article
  • Streptococcus iniae Discitis in Singapore PDF Version [PDF - 54 KB - 3 pages]
    T. H. Koh et al.
            Cite This Article
    EID Koh TH, Kurup A, Chen J. Streptococcus iniae Discitis in Singapore. Emerg Infect Dis. 2004;10(9):1694-1696. https://dx.doi.org/10.3201/eid1009.040029
    AMA Koh TH, Kurup A, Chen J. Streptococcus iniae Discitis in Singapore. Emerging Infectious Diseases. 2004;10(9):1694-1696. doi:10.3201/eid1009.040029.
    APA Koh, T. H., Kurup, A., & Chen, J. (2004). Streptococcus iniae Discitis in Singapore. Emerging Infectious Diseases, 10(9), 1694-1696. https://dx.doi.org/10.3201/eid1009.040029.
        Email Email this Article
  • Rubella Epidemic Strain, Greece, 1999 PDF Version [PDF - 25 KB - 2 pages]
    A. Papa et al.
            Cite This Article
    EID Papa A, Gioula G, Antoniadis A, Kyriazopoulou-Dalaina V. Rubella Epidemic Strain, Greece, 1999. Emerg Infect Dis. 2004;10(9):1696-1697. https://dx.doi.org/10.3201/eid1009.040117
    AMA Papa A, Gioula G, Antoniadis A, et al. Rubella Epidemic Strain, Greece, 1999. Emerging Infectious Diseases. 2004;10(9):1696-1697. doi:10.3201/eid1009.040117.
    APA Papa, A., Gioula, G., Antoniadis, A., & Kyriazopoulou-Dalaina, V. (2004). Rubella Epidemic Strain, Greece, 1999. Emerging Infectious Diseases, 10(9), 1696-1697. https://dx.doi.org/10.3201/eid1009.040117.
        Email Email this Article
  • CTX-M β-Lactamase-producing Escherichia coli in Long-term Care Facilities, France PDF Version [PDF - 26 KB - 2 pages]
    N. Kassis-Chikhani et al.
            Cite This Article
    EID Kassis-Chikhani N, Vimont S, Asselat K, Trivalle C, Minassian B, Sengelin C, et al. CTX-M β-Lactamase-producing Escherichia coli in Long-term Care Facilities, France. Emerg Infect Dis. 2004;10(9):1697-1698. https://dx.doi.org/10.3201/eid1009.030969
    AMA Kassis-Chikhani N, Vimont S, Asselat K, et al. CTX-M β-Lactamase-producing Escherichia coli in Long-term Care Facilities, France. Emerging Infectious Diseases. 2004;10(9):1697-1698. doi:10.3201/eid1009.030969.
    APA Kassis-Chikhani, N., Vimont, S., Asselat, K., Trivalle, C., Minassian, B., Sengelin, C....Arlet, G. (2004). CTX-M β-Lactamase-producing Escherichia coli in Long-term Care Facilities, France. Emerging Infectious Diseases, 10(9), 1697-1698. https://dx.doi.org/10.3201/eid1009.030969.
        Email Email this Article
  • Do Antiborrelial Antibodies Suggest Lyme Disease in Cuba? PDF Version [PDF - 30 KB - 3 pages]
    I. Rodríguez et al.
            Cite This Article
    EID Rodríguez I, Fernández C, Cinco M, Pedroso R, Fuentes O. Do Antiborrelial Antibodies Suggest Lyme Disease in Cuba?. Emerg Infect Dis. 2004;10(9):1698-1700. https://dx.doi.org/10.3201/eid1009.031048
    AMA Rodríguez I, Fernández C, Cinco M, et al. Do Antiborrelial Antibodies Suggest Lyme Disease in Cuba?. Emerging Infectious Diseases. 2004;10(9):1698-1700. doi:10.3201/eid1009.031048.
    APA Rodríguez, I., Fernández, C., Cinco, M., Pedroso, R., & Fuentes, O. (2004). Do Antiborrelial Antibodies Suggest Lyme Disease in Cuba?. Emerging Infectious Diseases, 10(9), 1698-1700. https://dx.doi.org/10.3201/eid1009.031048.
        Email Email this Article
  • Human Herpesvirus 6 Encephalomyelitis PDF Version [PDF - 49 KB - 3 pages]
    J. L. Soto-Hernandez
            Cite This Article
    EID Soto-Hernandez JL. Human Herpesvirus 6 Encephalomyelitis. Emerg Infect Dis. 2004;10(9):1700-1702. https://dx.doi.org/10.3201/eid1009.040365
    AMA Soto-Hernandez JL. Human Herpesvirus 6 Encephalomyelitis. Emerging Infectious Diseases. 2004;10(9):1700-1702. doi:10.3201/eid1009.040365.
    APA Soto-Hernandez, J. L. (2004). Human Herpesvirus 6 Encephalomyelitis. Emerging Infectious Diseases, 10(9), 1700-1702. https://dx.doi.org/10.3201/eid1009.040365.
        Email Email this Article
  • Vancomycin Heteroresistance in Methicillin-resistant Staphylococcus aureus, Taiwan PDF Version [PDF - 51 KB - 3 pages]
    J. Wang et al.
            Cite This Article
    EID Wang J, Tseng S, Hsueh P, Hiramatsu K. Vancomycin Heteroresistance in Methicillin-resistant Staphylococcus aureus, Taiwan. Emerg Infect Dis. 2004;10(9):1702-1704. https://dx.doi.org/10.3201/eid1009.040239
    AMA Wang J, Tseng S, Hsueh P, et al. Vancomycin Heteroresistance in Methicillin-resistant Staphylococcus aureus, Taiwan. Emerging Infectious Diseases. 2004;10(9):1702-1704. doi:10.3201/eid1009.040239.
    APA Wang, J., Tseng, S., Hsueh, P., & Hiramatsu, K. (2004). Vancomycin Heteroresistance in Methicillin-resistant Staphylococcus aureus, Taiwan. Emerging Infectious Diseases, 10(9), 1702-1704. https://dx.doi.org/10.3201/eid1009.040239.
        Email Email this Article

Books and Media

  • A Clinician’s Dictionary of Pathogenic Microorganisms PDF Version [PDF - 48 KB - 1 page]
    D. Raoult
            Cite This Article
    EID Raoult D. A Clinician’s Dictionary of Pathogenic Microorganisms. Emerg Infect Dis. 2004;10(9):1705. https://dx.doi.org/10.3201/eid1009.040540
    AMA Raoult D. A Clinician’s Dictionary of Pathogenic Microorganisms. Emerging Infectious Diseases. 2004;10(9):1705. doi:10.3201/eid1009.040540.
    APA Raoult, D. (2004). A Clinician’s Dictionary of Pathogenic Microorganisms. Emerging Infectious Diseases, 10(9), 1705. https://dx.doi.org/10.3201/eid1009.040540.
        Email Email this Article
  • Cryptosporidium: From Molecules to Disease
    T. J. Wade
            Cite This Article
    EID Wade TJ. Cryptosporidium: From Molecules to Disease. Emerg Infect Dis. 2004;10(9):1705-1706. https://dx.doi.org/10.3201/eid1009.040566
    AMA Wade TJ. Cryptosporidium: From Molecules to Disease. Emerging Infectious Diseases. 2004;10(9):1705-1706. doi:10.3201/eid1009.040566.
    APA Wade, T. J. (2004). Cryptosporidium: From Molecules to Disease. Emerging Infectious Diseases, 10(9), 1705-1706. https://dx.doi.org/10.3201/eid1009.040566.
        Email Email this Article

About the Cover

  • Measurable Indicators and Public Health PDF Version [PDF - 116 KB - 2 pages]
    P. Potter
            Cite This Article
    EID Potter P. Measurable Indicators and Public Health. Emerg Infect Dis. 2004;10(9):1709-1710. https://dx.doi.org/10.3201/eid1009.AC1009
    AMA Potter P. Measurable Indicators and Public Health. Emerging Infectious Diseases. 2004;10(9):1709-1710. doi:10.3201/eid1009.AC1009.
    APA Potter, P. (2004). Measurable Indicators and Public Health. Emerging Infectious Diseases, 10(9), 1709-1710. https://dx.doi.org/10.3201/eid1009.AC1009.
        Email Email this Article

Conference Summaries

  • Transnational Issues in Quarantine PDF Version [PDF - 15 KB - 1 page]
    C. DiGiovanni et al.
            Cite This Article
    EID DiGiovanni C, Conley J, Hamon D, Pimsler M. Transnational Issues in Quarantine. Emerg Infect Dis. 2004;10(9):1707. https://dx.doi.org/10.3201/eid1009.040281
    AMA DiGiovanni C, Conley J, Hamon D, et al. Transnational Issues in Quarantine. Emerging Infectious Diseases. 2004;10(9):1707. doi:10.3201/eid1009.040281.
    APA DiGiovanni, C., Conley, J., Hamon, D., & Pimsler, M. (2004). Transnational Issues in Quarantine. Emerging Infectious Diseases, 10(9), 1707. https://dx.doi.org/10.3201/eid1009.040281.
        Email Email this Article

Corrections

News and Notes

  • Ethics and Epidemics
    R. Baker et al.
            Cite This Article
    EID Baker R, Shelton W, Strosberg M. Ethics and Epidemics. Emerg Infect Dis. 2004;10(9):1707-1708. https://dx.doi.org/10.3201/eid1009.040407
    AMA Baker R, Shelton W, Strosberg M. Ethics and Epidemics. Emerging Infectious Diseases. 2004;10(9):1707-1708. doi:10.3201/eid1009.040407.
    APA Baker, R., Shelton, W., & Strosberg, M. (2004). Ethics and Epidemics. Emerging Infectious Diseases, 10(9), 1707-1708. https://dx.doi.org/10.3201/eid1009.040407.
        Email Email this Article
TOP